Hasil Pencarian (1)
small molecule | CAS: 941678-49-5
Ruxolitinib, formerly known as INCB018424 or INC424, is an anticancer drug and a Janus kinase (JAK) inhibitor. It is a potent and selective inhibitor of JAK1 and JAK2,[A229698] which are tyrosine kinases involved in cytokine signalling and hematopoiesis.[A745…
Kategori:
Agents for Dermatitis, Excluding CorticosteroidsAntineoplastic AgentsAntineoplastic and Immunomodulating Agents
+18
Target Protein:
Urokinase plasminogen activator surface receptorTyrosine-protein kinase JAK2Tyrosine-protein kinase JAK1
+2
Waktu ParuhThe mean eliminatio…
Vol. DistribusiThe mean volume of …
KlirensRuxolitinib clearan…
Genetik
-